Symptom Severity and Clinical Variables of Polycythemia Vera Patients with Splenomegaly, Phlebotomy Requirements and/or Hydroxyurea Use: a Retrospective Evaluation of 1334 Patients
Holly L. Geyer(Mayo Clinic Hospital), Ruben A. Mesa(Atrium Health Wake Forest Baptist), Jean‐Jacques Kiladjian(Délégation Paris 5), Francesco Passamonti(University of Milan), Frank Stegelmann(University Hospital Ulm), Pablo Muxí(Hospital Británico), Gunnar Birgegård(Uppsala University Hospital), Jean‐Christophe Ianotto(Inserm), Xiujuan Sun(Chinese Academy of Sciences), Heike L. Pahl(University Medical Center Freiburg), Federico Sackman(Fundación para la Investigación, Docencia y Prevención del Cáncer), Robyn M. Scherber(Blueprint Medicines (United States)), Francisco Cervantes(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Carlos Besses(Hospital Del Mar), Dolores Hernández‐Maraver(Centre Hospitalier Universitaire de Grenoble), Andreas Reiter(Heidelberg University), Thomas Lehmann(University of Basel), Deepti Radia(St Thomas' Hospital), Maria Luisa Ferrari(University of Bergamo), Harry C. Schouten, Jean‐Yves Cahn, Alessandro M. Vannucchi(Azienda Ospedaliero-Universitaria Careggi), Claire Harrison(Guy's and St Thomas' NHS Foundation Trust), Jan Samuelsson(Karolinska University Hospital), Peter Johansson(Linköping University), Konstanze Döhner(University Hospital Ulm), Björn Andréasson(NU Hospital Group), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Peter A.W. te Boekhorst(Erasmus MC), Zhijian Xiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Tiziano Barbui(University of Bergamo), Gabriel Étienne(Institut Bergonié), Karin Bonatz(Centre Hospitalier Universitaire de Grenoble), Dana Ranta(Centre Hospitalier Régional et Universitaire de Nancy), Sonja Zweegman(Vrije Universiteit Amsterdam), Giovanni Barosi(Policlinico San Matteo Fondazione), Amylou C. Dueck(Mayo Clinic in Arizona), Yue Zhang(Guilin Medical University), Zefeng Xu(Henan University), Peihong Zhang(Tongji University), Junqing Xu(Shenzhen University), Norman I Maldonado(University of Puerto Rico System), Keith Cannon(Mayo Clinic in Arizona), Stephanie Slot(Amsterdam UMC Location Vrije Universiteit Amsterdam), Françoise Boyer(Centre Hospitalier Universitaire d'Angers), Martin Grießhammer(Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie), Ana Kerguelen Fuentes(Centre Hospitalier Universitaire de Grenoble), Lydia Roy(Centre Hospitalier Universitaire de Poitiers)
Cited by 3
Related Papers
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k